688426.SHG Jiangsu Cowin Biotech Co. Ltd. A

Healthcare Biotechnology Shanghai Stock Exchange
17.72 CNY
Close of Nov 4, 2026
14.42 33.67
Market cap
CNY 1.99B
P/E
-
P/B
1.48x
ROE
-5.3%
Dividend yield
0.01%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688426.SHG undervalued?

Graham number

The Graham number of Jiangsu Cowin Biotech Co. Ltd. A cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Jiangsu Cowin Biotech Co. Ltd. A fundamental analysis

No fundamental analysis for Jiangsu Cowin Biotech Co. Ltd. A yet.

Jiangsu Cowin Biotech Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Jiangsu Cowin Biotech Co. Ltd. A

Jiangsu CoWin Biotech Co., Ltd. engages in the research, development, sales, testing, and technology services of biological reagents in China. The company offers RT-PCR, PCR, multiplex PCR, and qPCR; collection, such as cfDNA, fecal DNA, saliva DNA, and urine DNA storage tube, as well as other collection products; cfDNA, genomic DNA, FFPE DNA extraction, and plasmid kit; molecular raw materials; quantitative analysis, RNA sequencing, adapter, purification magbeads, DNA seque…

Full company profile